This was consistent with clinical outcomes in these subgroups; breast cancer‐specific survival in the CEP55‐high, CNA‐high group was significantly shorter than cases with lower CEP55 expression and fewer CNAs (P < 0.0001; Fig 2G). Here, CEP55 is linked to breast carcinoma.